Matthew T. Blahna

984 total citations
13 papers, 781 citations indexed

About

Matthew T. Blahna is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Matthew T. Blahna has authored 13 papers receiving a total of 781 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Matthew T. Blahna's work include RNA modifications and cancer (4 papers), MicroRNA in disease regulation (4 papers) and RNA Research and Splicing (3 papers). Matthew T. Blahna is often cited by papers focused on RNA modifications and cancer (4 papers), MicroRNA in disease regulation (4 papers) and RNA Research and Splicing (3 papers). Matthew T. Blahna collaborates with scholars based in United States, Japan and Sweden. Matthew T. Blahna's co-authors include Akiko Hata, Joseph P. Mizgerd, Matthew R. Jones, Lee J. Quinton, Dieter A Wolf, Suneng Fu, Alexander R. Ivanov, Joel R. Neilson, Carl F. Marrs and Betsy Foxman and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Matthew T. Blahna

13 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew T. Blahna United States	10	467	309	118	102	102	13	781
Gorjana Rackov Spain	11	379 0.8×	141 0.5×	137 1.2×	55 0.5×	172 1.7×	13	678
Ke Wei China	12	243 0.5×	107 0.3×	127 1.1×	49 0.5×	139 1.4×	29	516
Bing Liang China	14	246 0.5×	170 0.6×	50 0.4×	140 1.4×	26 0.3×	24	571
Shipeng Sun China	13	321 0.7×	230 0.7×	44 0.4×	49 0.5×	42 0.4×	20	505
Myung Hwa Chae South Korea	13	307 0.7×	120 0.4×	145 1.2×	35 0.3×	23 0.2×	18	612
Luis Miguel Guachalla Germany	14	431 0.9×	57 0.2×	139 1.2×	115 1.1×	138 1.4×	18	845
Yingzhao Liu China	13	203 0.4×	188 0.6×	57 0.5×	73 0.7×	348 3.4×	27	701
Ruting Xie China	18	499 1.1×	263 0.9×	37 0.3×	54 0.5×	85 0.8×	38	778
Farah Nassar Lebanon	18	642 1.4×	455 1.5×	30 0.3×	78 0.8×	62 0.6×	35	1.0k
Bahaeldin K. Elamin Sudan	11	323 0.7×	271 0.9×	60 0.5×	65 0.6×	27 0.3×	15	495

Countries citing papers authored by Matthew T. Blahna

Since Specialization

Citations

This map shows the geographic impact of Matthew T. Blahna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew T. Blahna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew T. Blahna more than expected).

Fields of papers citing papers by Matthew T. Blahna

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew T. Blahna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew T. Blahna. The network helps show where Matthew T. Blahna may publish in the future.

Co-authorship network of co-authors of Matthew T. Blahna

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew T. Blahna. A scholar is included among the top collaborators of Matthew T. Blahna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew T. Blahna. Matthew T. Blahna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Kaufman, Peter A., Naomi Schwartz, Shu Wang, et al.. (2023). Real-world patient characteristics, treatment patterns, and clinical outcomes associated with tucatinib therapy in HER2-positive metastatic breast cancer. Frontiers in Oncology. 13. 7 indexed citations

Anders, Carey K., Naomi Schwartz, Karen Bartley, et al.. (2023). Real-world patient characteristics and treatment patterns associated with tucatinib therapy in patients with HER2+ metastatic breast cancer.. Journal of Clinical Oncology. 41(16_suppl). 1051–1051. 2 indexed citations

DeBusk, Kendra, et al.. (2021). Efficacy of Tucatinib for HER2-Positive Metastatic Breast Cancer After HER2-Targeted Therapy: A Network Meta-Analysis. Future Oncology. 17(33). 4635–4647. 7 indexed citations

Coleman, Fadie T., Matthew T. Blahna, Hirofumi Kamata, et al.. (2017). Capacity of Pneumococci to Activate Macrophage Nuclear Factor κB: Influence on Necroptosis and Pneumonia Severity. The Journal of Infectious Diseases. 216(4). 425–435. 21 indexed citations

Wilson, Andrew A., Letty W. Kwok, Emily Porter, et al.. (2013). Lentiviral Delivery of RNAi for In Vivo Lineage-Specific Modulation of Gene Expression in Mouse Lung Macrophages. Molecular Therapy. 21(4). 825–833. 57 indexed citations

Blahna, Matthew T. & Akiko Hata. (2013). Regulation of miRNA biogenesis as an integrated component of growth factor signaling. Current Opinion in Cell Biology. 25(2). 233–240. 58 indexed citations

Jones, Matthew R., Matthew T. Blahna, Joseph D. Ferrari, et al.. (2012). Zcchc11 Uridylates Mature miRNAs to Enhance Neonatal IGF-1 Expression, Growth, and Survival. PLoS Genetics. 8(11). e1003105–e1003105. 47 indexed citations

Quinton, Lee J., Matthew T. Blahna, Matthew R. Jones, et al.. (2012). Hepatocyte-specific mutation of both NF-κB RelA and STAT3 abrogates the acute phase response in mice. Journal of Clinical Investigation. 122(5). 1758–1763. 66 indexed citations

Blahna, Matthew T. & Akiko Hata. (2012). Smad‐mediated regulation of microRNA biosynthesis. FEBS Letters. 586(14). 1906–1912. 98 indexed citations

10.

Blahna, Matthew T., et al.. (2011). Terminal Uridyltransferase Enzyme Zcchc11 Promotes Cell Proliferation Independent of Its Uridyltransferase Activity. Journal of Biological Chemistry. 286(49). 42381–42389. 17 indexed citations

11.

Jones, Matthew R., Lee J. Quinton, Matthew T. Blahna, et al.. (2009). Zcchc11-dependent uridylation of microRNA directs cytokine expression. Nature Cell Biology. 11(9). 1157–1163. 245 indexed citations

12.

Blahna, Matthew T., Christy Zalewski, Jennifer Reuer, et al.. (2006). The role of horizontal gene transfer in the spread of trimethoprim–sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. Journal of Antimicrobial Chemotherapy. 57(4). 666–672. 137 indexed citations

13.

France, Anne Marie, Kiersten J. Kugeler, Alison Freeman, et al.. (2005). Clonal Groups and the Spread of Resistance to Trimethoprim‐Sulfamethoxazole in UropathogenicEscherichia coli. Clinical Infectious Diseases. 40(8). 1101–1107. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact